Prof. Carolyn Bertozzi

           

Prof. Carolyn Bertozzi is a native of Boston, MA and attended Harvard University
as an undergraduate where she earned her A.B. in Chemistry in 1988. She moved to
UC Berkeley to pursue a Ph.D. in Chemistry working with Professor Mark Bednarski
on the synthesis and biological activity of C-glycosides. After graduating in
1993, she pursued postdoctoral research at UCSF with Professor Steven Rosen,
studying the activity of endothelial oligosaccharides in promoting leukocyte
adhesion at sites of inflammation. Prof. Bertozzi returned to Berkeley as a
member of the faculty in 1996.

Prof. Bertozzi is now Director of the Molecular Foundry at the Lawrence Berkeley
National Laboratory and an Investigator of the Howard Hughes Medical Institute.
She is the T.Z. and Irmgard Chu Distinguished Professor of Chemistry and Professor
of Molecular and Cell Biology at UC Berkeley, and Professor of Molecular and
Cellular Pharmacology at UCSF. Prof. Bertozzi is member of several Scientific
Advisory Boards of biotechnology and pharmaceutical companies, and an editorial
board member for numerous scientific journals. She is co-Editor-in-Chief of
Current Opinion in Chemical Biology. Prof. Bertozzi is a member of the National
Academy of Science and the American Academy of Arts and Sciences, and has been
recognized with numerous awards including a MacArthur Foundation award, ACS Award
in Pure Chemistry, Irving Sigal Award from the Protein Society, Presidential
Early Career Award in Science and Engineering, ACS Cope Scholars award, and the
UC Berkeley Distinguished Teaching Award.

Prof. Bertozzi’s research focuses on applications of chemistry and nanoscience
in the study of cellular processes. Her group has developed chemical approaches
for profiling changes in cell surface glycosylation associated with cancer and
identified metabolic pathways in Mycobacterium tuberculosis that are candidate
drug targets. In addition, Prof. Bertozzi’s group has developed new materials
engineered at the nanometer scale to mimic the biological materials mucin and
bone. Finally, her group has developed biomimetic coatings for nanotubes that
enable their use in biological systems.

Back to Program